Association of Sex Mismatch Between Donor and Recipient With Graft Survivorship at 5 Years After Osteochondral Allograft Transplantation

Carregando...
Imagem de Miniatura
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
SAGE PUBLICATIONS INC
Autores
MERKELY, Gergo
FARINA, Evan M.
ACKERMANN, Jakob
GORTZ, Simon
LATTERMANN, Christian
GOMOLL, Andreas H.
Citação
AMERICAN JOURNAL OF SPORTS MEDICINE, v.50, n.3, p.681-688, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Sex mismatch between donor and recipient has been considered a potential contributor to adverse outcomes after solid organ transplantation. However, the influence of sex mismatching in osteochondral allograft (OCA) transplantation has yet to be determined. Purpose: To evaluate whether donor-recipient sex mismatching affects graft survival after OCA transplantation. Study Design: Cohort study; Level of evidence, 3. Methods: In this review of prospectively collected data, patients who underwent OCA transplantation between November 2013 and November 2017 by a single surgeon were analyzed. Cumulative survival was assessed via the Kaplan-Meier method using log-rank tests to compare patients with similar donor groups. Multivariable Cox regression analysis adjusted for patient age, graft size, and body mass index was used to evaluate the influence of donor-recipient sex on graft survival. Results: A total of 154 patients were included: 102 (66.2%) who received OCAs from a same-sex donor and 52 (33.8%) who received OCAs from a different-sex donor. At 5-year follow-up, a significantly lower graft survival rate was observed for different-sex donor transplantation in comparison with same-sex donorship (63% vs 92%; P = .01). When correcting for age, graft size, and body mass index, donor-recipient sex-mismatch transplantation demonstrated a 2.9-times greater likelihood to fail at 5 years compared with donor-recipient same-sex transplantation (95% CI, 1.11-7.44; P = .03). A subgroup analysis showed no significant difference in graft survival between the female-to-female and female-to-male groups (91% and 84%, respectively). Conversely, male-to-male transplantation demonstrated a significantly higher cumulative 5-year survival (94%; P = .04), whereas lower survival was found with male-to-female donorship (64%; P = .04). Multivariable Cox regression indicated a 2.6-times higher likelihood of failure for the male-to-female group in comparison with the other groups (95% CI, 1.03-6.69; P = .04). Male-to-male transplantation had a tendency toward decreased likelihood of OCA failure (hazard ratio, 0.33), although without statistical significance (95% CI, 0.11-1.01; P = .052). Conclusion: Mismatch between donor and recipient sex had a negative effect on OCA survival after transplantation, particularly in those cases when male donor tissue was transplanted into a female recipient.
Palavras-chave
osteochondral allograft, sex mismatch, articular cartilage
Referências
  1. Anderson DE, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118805441
  2. Bacsxch P., 1947, PROC ROY SOC EDINBURGH, V62B, P321
  3. BAILEY DW, 1971, TRANSPLANTATION, V11, P426, DOI 10.1097/00007890-197104000-00017
  4. BAILEY DW, 1971, TRANSPLANTATION, V11, P404, DOI 10.1097/00007890-197104000-00008
  5. BONFIGLIO M, 1955, ANN NY ACAD SCI, V59, P417, DOI 10.1111/j.1749-6632.1955.tb45956.x
  6. Briggs DT, 2015, CARTILAGE, V6, P203, DOI 10.1177/1947603515595072
  7. Bugbee W, 2012, J KNEE SURG, V25, P109, DOI 10.1055/s-0032-1313743
  8. Chahal J, 2013, ARTHROSCOPY, V29, P575, DOI 10.1016/j.arthro.2012.12.002
  9. Cotter Eric J, 2019, Arthrosc Sports Med Rehabil, V1, pe25, DOI 10.1016/j.asmr.2019.06.003
  10. Cotter EJ, 2018, ARTHROSCOPY, V34, P1105, DOI 10.1016/j.arthro.2017.10.043
  11. ELVES MW, 1976, CLIN ORTHOP RELAT R, P232
  12. Familiari F, 2018, AM J SPORT MED, V46, P3541, DOI 10.1177/0363546517732531
  13. Frank RM, 2018, AM J SPORT MED, V46, P181, DOI 10.1177/0363546517739625
  14. Frank RM, 2017, AM J SPORT MED, V45, P864, DOI 10.1177/0363546516676072
  15. FRIEDLAENDER GE, 1983, CLIN ORTHOP RELAT R, P58
  16. FULKERSON JP, 1983, CLIN ORTHOP RELAT R, P176
  17. Gracitelli GC, 2015, CARTILAGE, V6, P98, DOI 10.1177/1947603514566298
  18. Gracitelli GC, 2015, AM J SPORT MED, V43, P885, DOI 10.1177/0363546514565770
  19. Gross AE, 2005, CLIN ORTHOP RELAT R, P79, DOI 10.1097/01.blo.0000165845.21735.05
  20. Hertz MI, 2002, J HEART LUNG TRANSPL, V21, P950, DOI 10.1016/S1053-2498(02)00498-9
  21. Horton MT, 2013, AM J SPORT MED, V41, P2507, DOI 10.1177/0363546513500628
  22. Hunt HE, 2014, AM J SPORT MED, V42, P886, DOI 10.1177/0363546513518733
  23. KANDEL RA, 1985, CLIN ORTHOP RELAT R, P103
  24. KEISER H, 1973, FED PROC, V32, P1474
  25. LANGER F, 1974, J BONE JOINT SURG AM, VA 56, P297, DOI 10.2106/00004623-197456020-00007
  26. Lee S, 2019, AM J SPORT MED, V47, P1601, DOI 10.1177/0363546519841378
  27. Lewandrowski K U, 2001, J Orthop Sci, V6, P545, DOI 10.1007/s007760100011
  28. Li ZW, 2016, SCI REP-UK, V6, DOI 10.1038/srep29298
  29. LLOYD GJ, 1973, CAN J SURG, V16, P306
  30. Loeb L, 1926, AM J PATHOL, V2, P111
  31. MANSOUR JM, 1976, J BONE JOINT SURG AM, V58, P509, DOI 10.2106/00004623-197658040-00014
  32. Marshall MB, 2004, J THORAC CARDIOV SUR, V128, P352, DOI 10.1016/j.jtcvs.2004.05.014
  33. McCulloch PC, 2007, AM J SPORT MED, V35, P411, DOI 10.1177/0363546506295178
  34. Merkely G, 2021, CARTILAGE, V13, p311S, DOI 10.1177/1947603520968209
  35. Merkely G, 2020, AM J SPORT MED, V48, P3170, DOI 10.1177/0363546520956311
  36. Merkely G, 2021, CARTILAGE, V13, p1306S, DOI 10.1177/1947603519900792
  37. Mickevicius T, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0776-y
  38. Miklos DB, 2004, BLOOD, V103, P353, DOI 10.1182/blood-2003-03-0984
  39. Murphy RT, 2014, AM J SPORT MED, V42, P635, DOI 10.1177/0363546513516747
  40. OAKESHOTT RD, 1988, CLIN ORTHOP RELAT R, P283
  41. PACCOLA CAJ, 1979, ARCH ORTHOP TRAUM SU, V93, P253, DOI 10.1007/BF00450223
  42. Prendergast TW, 1998, ANN THORAC SURG, V65, P88, DOI 10.1016/S0003-4975(97)01105-3
  43. Puoti F, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0088-4
  44. Rustgi VK, 2002, LIVER TRANSPLANT, V8, P514, DOI 10.1053/jlts.2002.33457
  45. Scott DM, 1997, J MOL MED-JMM, V75, P103, DOI 10.1007/s001090050095
  46. Sirlin CB, 2001, RADIOLOGY, V219, P35, DOI 10.1148/radiology.219.1.r01ap0435
  47. STEVENSON S, 1987, J BONE JOINT SURG AM, V69A, P573, DOI 10.2106/00004623-198769040-00015
  48. Tan JC, 2008, TRANSPLANTATION, V86, P75, DOI 10.1097/TP.0b013e31817352b9
  49. TOMFORD WW, 1981, TRANSPL P, V13, P888
  50. VandeVord PJ, 2005, J ORTHOP RES, V23, P1059, DOI 10.1016/j.orthres.2004.12.004
  51. Wang D, 2018, AM J SPORT MED, V46, P581, DOI 10.1177/0363546517741465
  52. Weiss ES, 2009, CIRC-HEART FAIL, V2, P401, DOI 10.1161/CIRCHEARTFAILURE.108.844183
  53. Zorn E, 2004, J EXP MED, V199, P1133, DOI 10.1084/jem.20031560
  54. Zukowski M, 2011, TRANSPL P, V43, P2914, DOI 10.1016/j.transproceed.2011.08.068